Responses to Covid-19: Legal and Ethical Perspectives

Responses to Covid-19: Legal and Ethical Perspectives

Hospitals, pharmaceutical companies, non-governmental agencies providing health care and many other organizations are wondering whether to change their standards of practice due to Covid-19, but often face legal, ethical and bioethical challenges in doing so. How do they make these decisions? Join us for an interactive discussion with a distinguished panel, including, among others:

Unni Karunakara, former International President, MSF

Amrit Ray, MD, Global President, R&D and Medical, Pfizer Upjohn

David Hoffman, JD, Columbia University, Masters of Bioethics Program

Gloria Ramsey, JD, RN, Associate Dean, Johns Hopkins School of Nursing

Suzanne B. Goldberg, JD, Executive Vice President for University Life, Clinical Professor of Law, Columbia University

Robert Klitzman, MD, Moderator

Information Regarding New York CLE Credits:
Columbia Law School has been certified by the New York State Continuing Legal Education (CLE) Board as an Accredited Provider of CLE programs. Under New York State CLE regulations, this live simultaneous transmission non-transitional CLE Program will provide 2.0 credit hours that can be applied toward the Areas of Professional Practice Requirement. This CLE credit is awarded only to New York attorneys for full attendance of the Program in its entirety. Attorneys attending only part of the program are not eligible for partial credit. Attendance is determined by an attorney's submission of their attendance verification with appropriate course codes noted. On submission of the attendance verification, attorneys should also submit their completed Evaluation Form, provided at the Conference. Please note the NYS Certificates of Attendance will be sent to the email address as it appears in the register unless otherwise noted there.

For questions, please contact Sameer Ladha, Deputy Academic Director, MS in Bioethics Program, at shl2159@columbia.edu.